"Ofloxacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Descriptor ID |
D015242
|
MeSH Number(s) |
D03.633.100.810.835.322.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ofloxacin".
Below are MeSH descriptors whose meaning is more specific than "Ofloxacin".
This graph shows the total number of publications written about "Ofloxacin" by people in this website by year, and whether "Ofloxacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1999 | 2 | 0 | 2 |
2001 | 1 | 1 | 2 |
2002 | 1 | 0 | 1 |
2003 | 0 | 4 | 4 |
2004 | 0 | 1 | 1 |
2005 | 1 | 1 | 2 |
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 3 | 4 |
2009 | 1 | 0 | 1 |
2010 | 2 | 2 | 4 |
2011 | 0 | 3 | 3 |
2012 | 2 | 2 | 4 |
2013 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ofloxacin" by people in Profiles.
-
Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge. Pediatr Blood Cancer. 2013 Sep; 60(9):1503-6.
-
Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy. Helicobacter. 2013 Oct; 18(5):373-7.
-
In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization. Antimicrob Agents Chemother. 2013 Jan; 57(1):621-5.
-
Which Therapy for Helicobacter pylori Infection? Gastroenterology. 2012 Jul; 143(1):10-2.
-
Guide regarding choice of second-line therapy to obtain a high cumulative cure rate. Helicobacter. 2012 Aug; 17(4):243-5.
-
Legionella micdadei prosthetic valve endocarditis complicated by brain abscess: case report and review of the literature. Scand J Infect Dis. 2012 Jun; 44(6):414-8.
-
Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli. Antimicrob Agents Chemother. 2012 Apr; 56(4):1680-5.
-
Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas. J Clin Microbiol. 2011 Aug; 49(8):2942-5.
-
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa. PLoS One. 2011; 6(5):e17513.
-
Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design. J Antimicrob Chemother. 2011 May; 66(5):1079-86.